tVNS® Transcutaneous Auricular Vagus Nerve Stimulation Device

Indications : Reduction of seizures in Epilepsy, Migraine, Depression Neuromodulation Research Areas : Alzheimer, Anxiety, Atrial Fibrillation, Autism, Coma recovery, Crohn's Disease, IBS, IBD, Stroke, Sleep Disorders, Tinnitus, Parkinson's, Neurology tVNS® is the world's only non-invasive auricular vagus nerve stimulation device approved as a Class IIa medical device under the EU-MDR. tVNS® device stimulates the auricular branch of the vagus nerve (ABVN) through the skin with gentle and precise electrical impulses that propagate therapeutic signals to the brain, first to the brain stem and then to higher centers, aiming to correct dysregulation within the nervous system. The application of tVNS® is designed with the patient in mind: it is easy, portable, and discreet, making it possible to incorporate treatment sessions into your schedule without interruption to your daily tasks. tVNS® provides a consistent and accessible means The innovative tVNS® Patient App is a wellness and session-diary application designed to help users keep a record of their well-being and the duration of their stimulation sessions with tVNS® device. tVNS® also Pioneers Neuromodulation Research and Trusted by Leading Institutions Worldwide : With its precise cymba concha stimulation and wireless parameter flexibility, tVNS offers cutting-edge technology and unparalleled flexibility to explore new therapeutic protocols. The Triggerbox, with the optional apparatus of tVNS, advances neuromodulation research by providing a cable-bound system that minimizes latencies and enhances protocol reproducibility to set-up closed loop neuromodulation.